Archives
-
uPAR–uPA Inhibition in Breast Cancer Metastasis
2026-09-11
This study established an evidence chain for compound 4, a small-molecule inhibitor of the uPAR–uPA protein–protein interaction, spanning synthesis, direct binding, cellular invasion assays, pharmacokinetics, and a breast cancer metastasis model. The results support compound 4 as an early chemical template with measurable tumor exposure and antimetastatic activity, while also showing why improved pharmacokinetics and further validation are required.
-
Jasplakinolide Workflows for Actin Polymerization
2026-09-11
Jasplakinolide is a membrane-permeable actin polymerization inducer that also stabilizes pre-existing filaments, enabling controlled perturbation of cytoskeletal organization. This practical guide covers dose finding, imaging, antifungal and antiproliferative workflows, assay controls, and troubleshooting for reproducible cell biology experiments.
-
AM251 CB1 Receptor Antagonist Workflows
2026-09-10
AM251 gives researchers a nanomolar tool for separating CB1-dependent signaling from broader cannabinoid effects in neural, metabolic, and cell-state assays. This workflow-focused guide connects the compound to pain circuitry, obesity treatment research, apoptosis assays, and practical troubleshooting.
-
5-EdU: Translational Precision in Neural Proliferation
2026-09-10
5-Ethynyl-2'-deoxyuridine (5-EdU) converts a transient S phase DNA synthesis event into a sensitive, microscopy- and flow-compatible readout. This thought-leadership perspective connects the chemistry of click-based labeling with prenatal neurodevelopment research, using an esketamine exposure study to show how proliferation data can strengthen translational experimental design.
-
Triazole ALDH2 Activators for Myocardial Ischemia
2026-09-09
The reference study reports a structure-guided series of triazole aldehyde dehydrogenase 2 activators designed to address oxidative aldehyde injury during myocardial ischemia-reperfusion. Its lead compound improved ALDH2 activation, cardiac function, and biochemical injury markers in a mouse model, while also illustrating how molecular simulation can guide optimization of solubility and activity.
-
Griseofulvin: From Microtubules to Translation
2026-09-09
A mechanism-first perspective on using Griseofulvin to connect fungal mitosis, microtubule dynamics, and aneugenicity profiling while improving assay design and translational decision-making.
-
HyperScript First-Strand cDNA Synthesis Kit for HFpEF
2026-09-08
Translate HFpEF pathway biology into a reproducible RNA-to-qPCR workflow with stronger support for structured and low-abundance transcripts. The HyperScript First-Strand cDNA Synthesis Kit combines primer flexibility, thermal-stable reverse transcription, and long cDNA capability for cardiac gene-expression studies.
-
ML-7 hydrochloride: MLCK Workflow Guide
2026-09-08
ML-7 hydrochloride enables controlled interrogation of myosin light chain kinase signaling in cardiac, endothelial, and cancer-cell models. This practical guide connects mechanism-focused assay design with dosing, storage, readout selection, and troubleshooting strategies.
-
Nitrocefin Assays for β-Lactamase Research
2026-09-07
Nitrocefin provides a rapid visual and spectrophotometric route to β-lactamase activity measurement, from purified enzymes to resistance-focused microbial workflows. This guide translates the GOB-38 findings in Elizabethkingia anophelis into practical assay design, inhibitor-screening controls, and troubleshooting decisions.
-
Griseofulvin: From Spindle Biology to Translation
2026-09-07
A translational framework for using Griseofulvin to interrogate fungal mitosis, microtubule dynamics, and mechanism-aware antifungal research while connecting experimental design to aneugenicity assessment.
-
ARCA EGFP mRNA: From Signal to Strategy
2026-09-05
A mechanistic and translational guide to using ARCA EGFP mRNA (5-moUTP) as a reproducible fluorescence-based transfection control, with practical insight into cap orientation, modified uridine, polyadenylation, storage, and assay validation.
-
Gingerenone A Reverses Sunitinib Resistance in RCC
2026-09-04
The reference study identifies gingerenone A as an inhibitor of LDHA-driven glycolysis in renal cell carcinoma and links metabolic suppression to reduced HIF-1α/VEGFA/VEGFR2 signaling. Its combination with sunitinib improved activity in sensitive and resistant preclinical models, supporting metabolic intervention as a strategy for restoring TKI responsiveness.
-
Resiniferatoxin (RTX) Workflows for Pain Research
2026-09-04
Resiniferatoxin (RTX) gives researchers a highly selective way to activate, desensitize, and chemically inactivate TRPV1-positive sensory neurons. This practical guide connects calcium-imaging assays with osteoarthritis, neuropathic, postoperative, and targeted pain-model workflows while emphasizing dose control, route-specific design, and reproducibility.
-
Indomethacin Workflows for Inflammation Research
2026-09-03
Indomethacin gives researchers a practical Cox-focused perturbation tool while also enabling PPARγ, lipid-metabolism, and membrane-organization experiments. This guide shows how to use it as an orthogonal comparator in FXR–KLF11 kidney-injury studies without overinterpreting pathway specificity.
-
Isorhamnetin and PI3K/Akt Oocyte Maturation
2026-09-03
A 2024 study found that Isorhamnetin improved porcine oocyte maturation in vitro, with 10 μM increasing polar body extrusion and reducing oxidative, mitochondrial, apoptotic, and endoplasmic-reticulum stress signals. The work’s main contribution is a mechanism-oriented link between these protective effects and PI3K/Akt pathway activation, while its reproductive and clinical relevance remains model-dependent.